We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Serum Iron Levels Measured Using Mobile Phone

By LabMedica International staff writers
Posted on 12 Dec 2013
Print article
Iron in blood serum has been visually detected and quantified quickly by processing photographs, taken with a conventional digital camera or Smartphone, of an iron colorimetric sensory polymer substrate.

Routine blood analysis usually determines the amount of iron in blood serum using ultraviolet-visible spectroscopy and this method requires an iron-complexing reagent to form differentially colored compounds. These reagents include reductants, complexing agents, precipitating agents, and buffered solutions.

Biochemists at the University of Burgos (Spain) developed a technique consists in putting a drop of the fluid on the material, a thin disc half a centimeter in diameter and 0.1 mm thickness, waiting fifteen minutes and comparing the result with a standard. This can be done by sight alone, but if the film is photographed with a mobile phone, the concentration of this biologically and commercially very significant metal can be measured better.

The sensory materials were designed following a straightforward strategy. A proven iron organic chelator, called 8-hydroxyquinoline, was easily transformed into an acrylic monomer and further copolymerized with hydrophilic co-monomers to render a membrane comprised of a hydrophilic, gel-like polymer network. The film-like membrane generated was cut into small-diameter sensory discs. Thus, upon immersion of the sensory disks in blood serum, wine, and water, a color development was rapidly observed which could be easily correlated with the iron concentration of the samples. For verification, high-resolution electron-impact mass spectrometry (EI-HRMS) was carried out on a Micromass AutoSpec mass spectrometer (Waters Corporation; Milford, MA, USA) and other instruments.

Red, green, and blue (RGB) digital parameters obtained from photographs of the sensors were processed statistically using principal component analysis (PCA) and used to elaborate titration curves and quantify iron concentrations. Ferric ions in blood serum have been visually detected using only the naked eye by immersing a sensory disc into the sample for a few minutes. The iron concentrations detected are between 56 parts per billion (ppb) and 56 parts per million (ppm). The normal level in blood serum, obtained by centrifugation of the blood, is 0.8 to 1.8 ppm.

José Miguel García, PhD, the senior author of the study said, “It is a smart polymeric material which changes color based on the concentration of iron cations Fe2+ and Fe3+ in an aqueous medium. RGB [red, green, blue] information can be obtained directly from the phone and processed on a conventional computer to determine the levels of the cation according to the reference system.” The study was published on October 24, 2013, in the Journal of Materials Chemistry A.

Related Links:

University of Burgos
Waters Corporation


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.